The Centers for Disease Control & Prevention (CDC) this month announced $77 million in funding to help state and local health departments combat antibiotic resistance through the agency’s Antibiotic Resistance Laboratory Network.
With this funding, the network will:
- increase nationwide testing for the Candida fungal threat, especially drug-resistant Candida auris;
- create a national laboratory dedicated to tuberculosis surveillance; and
- increase the use of whole genome sequencing to improve detection of drug-resistant gonorrhea threats, as well as to test for food and waterborne bacteria through the PulseNet laboratory network.
CDC made these investments through the Epidemiology and Laboratory Capacity for Infectious Disease Cooperative Agreement, through which the agency has awarded more than $300 million to state and local health departments to combat infectious disease.
Contact Director of Policy Erin O’Malley at eomalley@essentialhospitals.org or 202.585.0127 with questions.
